Companies: Humana · BlackRock · CenterWell · WCAS · HPS Investment Partners
BlackRock is taking over the majority financial interest in a network of nearly 150 CenterWell Senior Primary Care clinics. Humana is keeping operational control. That difference is the transaction: private capital is financing the physical footprint, while the insurer retains the system that connects senior patients, clinical operations, payer contracts, and care economics.
Humana announced October 13 that funds managed by HPS Investment Partners, part of BlackRock, will acquire the existing majority equity stake of Welsh, Carson, Anderson & Stowe (WCAS). The WCAS stake is valued at approximately $2.8 billion. This is not a $2.8 billion sale of all CenterWell clinics, nor a sale of Humana's entire primary care business.
CenterWell will remain minority owner and continue managing the clinics. The transaction is expected to close in Q4 2026 subject to regulatory approval, with no material change anticipated in Humana's 2026 adjusted earnings guidance.
Value of WCAS's majority equity stake acquired by BlackRock-managed funds; clinics within the joint venture, not the entirety of CenterWell's national footprint.
The companies say the new joint venture will invest in existing clinical operations, new centers, and acquisitions over the next two years. Humana expects additional growth capital, greater balance sheet flexibility, and lower financing costs.
The financing structure is central to the deal. Unlike the WCAS arrangement, the replacement joint venture does not include a put option. Humana expects to remove liabilities associated with the legacy put arrangements from its balance sheet, subject to negotiated protections for BlackRock.
CenterWell has options to purchase clinics beginning in 2028. If it has not bought all the remaining joint venture clinics by the end of 2033, BlackRock may initiate a sale process, with CenterWell retaining a right to make the first bid.
That is not permanent divestiture. It is a capital structure designed to support expansion while preserving a possible route back to full ownership.
The clinics are the capital asset. CenterWell's management and operating infrastructure is the strategic asset. The financial return depends on what happens inside the care model—not simply the number of locations the joint venture owns.
A traditional fee-for-service revenue cycle collects payment for individual services. Value-based primary care adds several layers: patient attribution, contract reconciliation, longitudinal documentation, quality performance, risk adjustment, medical costs, and payment settlement.
The release does not disclose the specific payer contract mix of these nearly 150 clinics. It would be misleading to assume every location is entirely capitated or that all revenue comes from Humana's insurance members. Humana describes CenterWell as payer agnostic, serving multiple Medicare Advantage plans and fee-for-service Medicare patients.
The resulting revenue cycle is not just claims, denials, and days in AR. It is whether the organization receives the correct payment under each agreement and delivers the associated care at sustainable cost.
Revenue cycle infrastructure in this model needs to bridge the EHR, payer contracts, attribution files, encounter submissions, quality reporting, and financial ledgers. Any break in that chain can distort performance—even if the clinical visit was properly delivered.
These are RCAI's analytical priorities for a senior-focused value-based care network. Humana has not announced a new RCM technology product or disclosed clinic-specific financial performance in connection with the transaction.
Humana's CenterWell organization includes more than 325 primary care centers across 15 states, according to its published company overview. The joint venture covers only a subset of clinics.
Humana's second-quarter 2026 report said CenterWell Senior Primary Care had added 130,900 patients year to date, or 27% through June 30. That broader growth provides context for why outside capital can be attractive. It does not establish that every new center is profitable.
Nor should ownership of clinics be confused with exclusive control over patient referral patterns. Clinical decision-making, payer neutrality, patient choice, and regulatory compliance all remain critical to the platform's legitimacy and future value.
HPS Investment Partners provides BlackRock's private financing capability. The firm is acquiring an investment in the clinic venture, while CenterWell continues the work of managing patient panels, physician teams, and long-term care delivery.
For an outside capital partner, the important metrics are likely to include new-center ramp times, patient retention, patient mix, medical cost performance, operating cash flow, and the economics of a future CenterWell repurchase or other exit.
One potential result is greater demand for systems that can make provider performance comparable across markets. A large network cannot manage hundreds of locations effectively with disconnected claims tools and spreadsheets alone.
But the transaction is still pending and carries material risks, including Medicare Advantage reimbursement pressure, staffing costs, regulatory scrutiny, and the complexity of aligning majority financial ownership with minority-owner operational control.
Humana is redesigning how a value-based care network gets financed without surrendering its operating model.
BlackRock's capital can support CenterWell expansion. Humana keeps the clinical and administrative workflows that determine whether those investments generate a return. The 2028 purchase options and 2033 potential exit underscore that this is a long-term partnership with multiple future outcomes, not a simple one-time clinic sale.
For RCM, the strategic signal is clear: as capital flows into senior-focused value-based care, revenue integrity increasingly requires payer-contract intelligence, accurate encounter reporting, compliant risk adjustment, reconciliation, and visibility into the full cost of care.
The clinic is the delivery asset. The value-based care operating system determines whether the investment works.
Independent analysis of healthcare capital, Medicare Advantage, payer behavior and the operating models reshaping revenue cycle.
Sources: Humana, Business Wire, October 13, 2026; Reuters transaction coverage; Humana CenterWell overview; Humana Q2 2026 results. Financial transaction terms and CenterWell figures come from the linked sources; RCM implications are independent RevCycleAI analysis.